Topical retinoids, which target retinoic acid receptors, are commonly used to treat acne. New research reveals that trifarotene, a fourth-generation retinoid with potent and selective activity against only one particular retinoic acid receptor, may have an improved efficacy and safety profile compared with less selective retinoids.